Dyne Therapeutics Ownership & Insider Activity

Dyne Therapeutics Inc

DYNNASDAQ

Trade with Public

$16.50

0.291.82%

마지막 업데이트: Sep 30, 10:22 AM

개요 뉴스 실적 전망 이벤트 목표가 재무 심리지분 현황비교 옵션 주식 보고서

Dyne Therapeutics Ownership & Insider Activity

Dyne Therapeutics (DYN) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.5% of shares outstanding. Institutional investors hold 67.9%. Over the past 90 days, insiders made 10 sales worth $90.2M.

Shares Outstanding

186.746M

Shares Float

146.015M

Insider Shares Owned

2.785M

Insider % Owned

1.5%

Institutional Shares Held

126.833M

Institutional % Held

67.9%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$90.2M total

Net Activity

Net Selling

Net Value (90d)

-$90.2M

Dyne Therapeutics Insider Transactions (Last 6 Months)

모든 내부자 거래 내역 보기 →

Date	Insider	Title	Type	Shares	Price	Value
Sep 8, 2026	John Cox	CEO & PRESIDENT	SELL	5.658K	$18.88	$107K
Sep 4, 2026	Johanna FriedlNaderer	CHIEF COMMERCIAL OFFICER	SELL	1.085K	$23.42	$25K
Sep 4, 2026	Douglas Kerr	CHIEF MEDICAL OFFICER	SELL	5.035K	$22.95	$116K
Aug 13, 2026	Jason Rhodes	—	SELL	2.587M	$25.20	$65.2M
Aug 13, 2026	Johanna FriedlNaderer	CHIEF COMMERCIAL OFFICER	SELL	226.000	$26.28	$6K
Aug 13, 2026	Douglas Kerr	CHIEF MEDICAL OFFICER	SELL	1.556K	$26.28	$41K
Aug 13, 2026	John Cox	CEO & PRESIDENT	SELL	4.986K	$26.28	$131K
Aug 13, 2026	Erick Lucera	CHIEF FINANCIAL OFFICER	SELL	1.797K	$26.28	$47K
Jul 27, 2026	Dirk Kersten	—	SELL	261.460K	$25.51	$6.7M
Jul 6, 2026	Jason Rhodes	—	SELL	777.451K	$22.97	$17.9M
Jun 26, 2026	Jason Rhodes	—	SELL	504.695K	$21.23	$10.7M
Jun 25, 2026	Erick Lucera	CHIEF FINANCIAL OFFICER	SELL	2.362K	$20.37	$48K
Jun 23, 2026	Jason Rhodes	—	SELL	267.760K	$21.09	$5.6M
Jun 22, 2026	Dirk Kersten	—	SELL	263.962K	$20.70	$5.5M
Jun 17, 2026	Dirk Kersten	—	SELL	84.355K	$20.10	$1.7M
Jun 16, 2026	Douglas Kerr	CHIEF MEDICAL OFFICER	SELL	887.000	$18.33	$16K
Jun 16, 2026	Johanna FriedlNaderer	CHIEF COMMERCIAL OFFICER	SELL	145.000	$18.33	$3K
Jun 16, 2026	John Cox	CEO & PRESIDENT	SELL	2.683K	$18.33	$49K
Jun 8, 2026	Brian Posner	—	BUY	2.000K	$16.94	$34K
Jun 3, 2026	Brian Posner	—	BUY	2.500K	$17.48	$44K
May 26, 2026	Brian Posner	—	BUY	2.000K	$18.21	$36K
May 20, 2026	Brian Posner	—	BUY	2.500K	$17.12	$43K
May 13, 2026	Johanna FriedlNaderer	CHIEF COMMERCIAL OFFICER	SELL	228.000	$18.36	$4K
May 13, 2026	Douglas Kerr	CHIEF MEDICAL OFFICER	SELL	1.564K	$18.36	$29K
May 13, 2026	Erick Lucera	CHIEF FINANCIAL OFFICER	SELL	1.448K	$18.36	$27K
May 13, 2026	John Cox	CEO & PRESIDENT	SELL	3.311K	$18.36	$61K
May 4, 2026	Jason Rhodes	—	SELL	106.723K	$18.14	$1.9M
Apr 28, 2026	Jason Rhodes	—	SELL	227.337K	$18.38	$4.2M
Apr 23, 2026	Jason Rhodes	—	SELL	384.549K	$18.47	$7.1M
Apr 21, 2026	Dirk Kersten	—	SELL	10.952K	$20.01	$219K
Apr 20, 2026	Jason Rhodes	—	SELL	834.302K	$19.75	$16.5M
Apr 17, 2026	Dirk Kersten	—	SELL	337.248K	$20.21	$6.8M
Apr 15, 2026	Dirk Kersten	—	SELL	99.613K	$20.35	$2.0M
Apr 1, 2026	Erick Lucera	CHIEF FINANCIAL OFFICER	SELL	5.727K	$18.64	$107K

More with Benzinga EdgeGet Access

Dyne Therapeutics Inc

Dyne Therapeutics Ownership & Insider Activity

Dyne Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

뉴스

파트너 / 기고자

벤징가 글로벌

People Also Watch